The effect of legal representation on clinical measures in involuntarily admitted psychiatric patients: a retrospective study.


Journal

Israel journal of health policy research
ISSN: 2045-4015
Titre abrégé: Isr J Health Policy Res
Pays: England
ID NLM: 101584158

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 05 08 2023
accepted: 02 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 3 10 2024
Statut: epublish

Résumé

Most western countries provide funded legal representation (LR) for involuntarily admitted psychiatric patients appearing before judicial committees. In 2004, an amendment to the Israeli Mental Health Act granted this right to involuntarily committed psychiatric patients. Psychiatrists then voiced concerns that LR may increase rates of premature discharge and compromise patients' safety and well-being. These worries have not been sufficiently addressed to date. This study aimed to provide answers to their concerns. This study included 3124 and 3434 inpatients involuntarily admitted to psychiatric facilities in 2000 and in 2010 (respectively), prior to and after the introduction of LR in Israel. Data were acquired from the Israeli National Psychiatric Hospitalization Registry. Clinical measures included percentage of discharges by the District Psychiatric Board (DPB), duration of involuntary hospitalization and rates of readmissions within thirty days and six months of discharge by treating psychiatrists (TP) or DPB. The odds ratio (OR) of discharge by a DPB in 2010 (n = 221) compared to 2000 (n = 93) was 2.2 [95%CI 1.72-2.82]. The OR was similar for readmissions within thirty days or six months among patients discharged by TP and a DPB (OR = 1.08, p = 0.697 and OR = 0.92, p = 0.603, respectively) as well as between the two time points (p = 0.486 and p = 0.618). The duration of hospitalizations terminated by a DPB was significantly shorter than those terminated by TP, with no difference between the study time points. The mean hospitalization duration in 2010 was 21% shorter compared to 2000 among patients discharged by TP. The number of DPB proceedings and the number of involuntarily hospitalized psychiatric patients discharged by DPBs increased considerably after the advent of state-funded legal representation in 2004. We found that this did not compromise beneficence and non-malfeasance of patient care. Our results emphasize the feasibility of affording even the most severely mentally ill patients the rights to due process. These findings may relieve concerns about state-funded LR procedures in involuntary psychiatric hospitalizations.

Sections du résumé

BACKGROUND BACKGROUND
Most western countries provide funded legal representation (LR) for involuntarily admitted psychiatric patients appearing before judicial committees. In 2004, an amendment to the Israeli Mental Health Act granted this right to involuntarily committed psychiatric patients. Psychiatrists then voiced concerns that LR may increase rates of premature discharge and compromise patients' safety and well-being. These worries have not been sufficiently addressed to date. This study aimed to provide answers to their concerns.
METHODS METHODS
This study included 3124 and 3434 inpatients involuntarily admitted to psychiatric facilities in 2000 and in 2010 (respectively), prior to and after the introduction of LR in Israel. Data were acquired from the Israeli National Psychiatric Hospitalization Registry. Clinical measures included percentage of discharges by the District Psychiatric Board (DPB), duration of involuntary hospitalization and rates of readmissions within thirty days and six months of discharge by treating psychiatrists (TP) or DPB.
RESULTS RESULTS
The odds ratio (OR) of discharge by a DPB in 2010 (n = 221) compared to 2000 (n = 93) was 2.2 [95%CI 1.72-2.82]. The OR was similar for readmissions within thirty days or six months among patients discharged by TP and a DPB (OR = 1.08, p = 0.697 and OR = 0.92, p = 0.603, respectively) as well as between the two time points (p = 0.486 and p = 0.618). The duration of hospitalizations terminated by a DPB was significantly shorter than those terminated by TP, with no difference between the study time points. The mean hospitalization duration in 2010 was 21% shorter compared to 2000 among patients discharged by TP.
CONCLUSIONS CONCLUSIONS
The number of DPB proceedings and the number of involuntarily hospitalized psychiatric patients discharged by DPBs increased considerably after the advent of state-funded legal representation in 2004. We found that this did not compromise beneficence and non-malfeasance of patient care. Our results emphasize the feasibility of affording even the most severely mentally ill patients the rights to due process. These findings may relieve concerns about state-funded LR procedures in involuntary psychiatric hospitalizations.

Identifiants

pubmed: 39363227
doi: 10.1186/s13584-024-00633-9
pii: 10.1186/s13584-024-00633-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

58

Informations de copyright

© 2024. The Author(s).

Références

Barrett JA. Hold or not to hold: navigating involuntary commitment. Curr Psychiatry. 2022;21(9):41–5. https://doi.org/10.12788/cp.0281 .
doi: 10.12788/cp.0281
Gutheil TG, Appelbaum PS. Clinical handbook of psychiatry and the law. Philadelphia: Lippincott Williams & Wilkins; 2019.
Perlin ML, Cucolo HE. Mental disability law: civil and criminal, 3rd ed.; 2017.
Zhang S, Mellsop G, Brink J, et al. Involuntary admission and treatment of patients with mental disorder. Neurosci Bull. 2015;31:99–112. https://doi.org/10.1007/s12264-014-1493-5 .
doi: 10.1007/s12264-014-1493-5 pubmed: 25595369 pmcid: 5562644
Testa M, West SG. Civil commitment in the United States. Psychiatry. 2010;7(10):30–40.
pubmed: 22778709 pmcid: 3392176
Mark M. Looking at involuntary psychiatric admission in Israel from a therapeutic jurisprudence lens. Kiryat Hamishpat. 2011; 83–166.
Wasserman D, Apter G, Baeken C, et al. Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries. European Psychiatry. 2020;63(1):e82. https://doi.org/10.1192/j.eurpsy.2020.79 .
doi: 10.1192/j.eurpsy.2020.79 pubmed: 32829740 pmcid: 7576531
Mark M. Determining the period of a criminal psychiatric order: looking from therapeutic jurisprudence lens; 2020.
McLachlan AJ, Mulder RT. Criteria for involuntary hospitalisation. Aust N Z J Psychiatry. 1999;33(5):729–33. https://doi.org/10.1046/j.1440-1614.1999.00636.x .
doi: 10.1046/j.1440-1614.1999.00636.x pubmed: 10544998
Mental Health Act. 2007. http://www.legislation.gov.uk/ukpga/2007/12/pdfs/ukpga_20070012_en.pdf . Accessed 8 Oct 2017.
De Stefano A, Ducci G. Involuntary admission and compulsory treatment in Europe: an overview. Int J Ment Health. 2008;37(3):10–21.
doi: 10.2753/IMH0020-7411370301
Dressing H, Salize HJ. Compulsory admission of mentally ill patients in European Union Member States. Soc Psychiatry Psychiatr Epidemiol. 2004;39(10):797–803.
doi: 10.1007/s00127-004-0814-9 pubmed: 15669660
Jacobsen TB. Involuntary treatment in Europe: different countries, different practices. Curr Opin Psychiatry. 2012;25(4):307–10.
doi: 10.1097/YCO.0b013e32835462e3 pubmed: 22569313
Israel Mental Health Act. 1991. Israel.
Asman O, Mark M, Raz D. Therapeutic jurisprudence and the significance of its implementation is the work of the district psychiatric committees. Med Law. 2023;53:147–61.
Israel Mental Health Act. 1991. Amendment Number 5. (2004). Israel.
Appelbaum PS, Gutheil TG. Clinical handbook of psychiatry and the law. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2020. p. 41–3.
Salize HJ, Dressing H. Epidemiology of involuntary placement of mentally ill people across the european union. Br J Psychiatry. 2004;184:163–8. https://doi.org/10.1192/bjp.184.2.163 .
doi: 10.1192/bjp.184.2.163 pubmed: 14754830
Raskin S, Teitelbaum A, Zislin J, Shlafman M, Durst R. Legal involvement in psychiatric care. Harefuah. 2005;144(10):696–999.
pubmed: 16281760
Maoz H, Kriger I. The influence of statutory representation for mentally ill involuntarily committed on the duration of the admission and the time for readmission. Harefuah. 2011;150(3):230–4.
pubmed: 21574353
Sheridan Rains L, Zenina T, Casanova Dias M, Jones R, Jefreys S, Branthonne-Foster S, et al. Variations in patterns of involuntary hospitalisation and in legal frameworks: an international comparative study. Lancet Psychiatry. 2019;6(5):403–17. https://doi.org/10.1016/S2215-0366(19)30090-2 .
doi: 10.1016/S2215-0366(19)30090-2 pubmed: 30954479 pmcid: 6475657
Anfang SA, Appelbaum PS. Civil commitment-the American experience. Israel J Psychiatry. 2006;43(3):209.
Cohen Y. Representation of the mentally ill in the psychiatric committee-the psychiatric point of view. [Unpublished Master’s Thesis]. Bar Ilan Univeristy; 2015.
Mark M. Psyco-therapeutic involuntary psychiatric treatment; 2022.
Vigod SN, Kurdyak PA, Seitz D, Herrmann N, Fung K, Lin E, Perlman C, Taylor VH, Rochon PA, Gruneir A. Readmit: a clinical risk index to predict 30-day readmission after discharge from acute psychiatric units. J Psychiatr Res. 2015;61:205–13. https://doi.org/10.1016/j.jpsychires.2014.12.003 .
doi: 10.1016/j.jpsychires.2014.12.003 pubmed: 25537450
Durbin J, Lin E, Layne C, Teed M. Is readmission a valid indicator of the quality of inpatient psychiatric care? J Behav Heal Serv Res. 2007;34(2):37–50. https://doi.org/10.1007/s11414-007-9055-5 .
doi: 10.1007/s11414-007-9055-5
Fisher WH, Geller JL, Altaffer F, Bennett MB. The relationship between community resources and state hospital recidivism. Am J Psychiatry. 1992;149(3):385–90. https://doi.org/10.1176/ajp.149.3.385 .
doi: 10.1176/ajp.149.3.385 pubmed: 1536279
Rumball-Smith J, Hider P. The validity of readmission rate as a marker of the quality of hospital care, and a recommendation for its definition. N Z Med J. 2009;122(1289):63–70.
pubmed: 19305451

Auteurs

Yaacov Cohen (Y)

Faculty of Law, Bar-Ilan University, Ramat Gan, Israel. yaacov.cohen3@mail.huji.ac.il.

Ariel L Bendor (AL)

Faculty of Law, Bar-Ilan University, Ramat Gan, Israel.

Roy Gilbar (R)

School of Law, Netanya Academic College, Netanya, Israel.

Orly Cohen (O)

Department of Biotechnology, Hadassah Academic College, Jerusalem, Israel.

Razek Khawaled (R)

Forensic Psychiatry Department, Mental Health Division, Ministry of Health & Hadassah Medical Center, Jerusalem, Israel.

Arieh Dienstag (A)

Department of Psychiatry, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Amit Lotan (A)

Department of Psychiatry, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Omer Bonne (O)

Department of Psychiatry, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH